You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

natalizumab

Showing 26 - 50 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn's Disease Trial in San Diego (natalizumab)

Completed
  • Crohn's Disease
  • natalizumab
  • San Diego, California
    Elan Pharmaceuticals
Jun 14, 2016

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Natalizumab, Placebo)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Natalizumab
  • Placebo
  • Scottsdale, Arizona
  • +52 more
Jan 5, 2017

Rheumatoid Arthritis Trial (natalizumab)

Terminated
  • Rheumatoid Arthritis
  • natalizumab
  • (no location specified)
Jun 14, 2016

Crohn's Disease Trial in San Diego (natalizumab)

Completed
  • Crohn's Disease
  • natalizumab
  • San Diego, California
    Performed only at CD251, CD301, CD303, CD306, and CD307 sites gl
Jun 14, 2016

Rheumatoid Arthritis Trial in Canada, United States (natalizumab, )

Terminated
Has Results
  • Rheumatoid Arthritis
  • natalizumab
  • placebo
  • Birmingham, Alabama
  • +11 more
Jul 14, 2016

Crohn's Disease Trial in United Kingdom, United States (natalizumab)

Completed
  • Crohn's Disease
  • natalizumab
  • Los Angeles, California
  • +12 more
Jun 14, 2016

Crohn's Disease Trial in United States (natalizumab)

Completed
  • Crohn's Disease
  • natalizumab
  • Gainesville, Florida
  • +17 more
Jun 14, 2016

Acute Ischemic Stroke Trial in Germany, Spain, United States (natalizumab, Placebo)

Completed
Has Results
  • Acute Ischemic Stroke
  • natalizumab
  • Placebo
  • San Diego, California
  • +49 more
May 24, 2016

Tecfidera Post-Tysabri

Completed
  • Relapsing-Remitting Multiple Sclerosis
  • natalizumab
  • dimethyl fumarate
  • Birmingham, Alabama
  • +42 more
Jun 4, 2016

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Natalizumab)

Terminated
Has Results
  • Relapsing-Remitting Multiple Sclerosis
  • Natalizumab
  • Camperdown, Australia
  • +111 more
Jun 16, 2016

Crohn's Disease Trial in Canada, United States (natalizumab)

Completed
  • Crohn's Disease
  • natalizumab
  • Oro Valley, Arizona
  • +74 more
Jun 14, 2016

Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri

Completed
  • Multiple Sclerosis
  • natalizumab
  • (no location specified)
Oct 16, 2015

Relapsing Forms of MS Receiving Treatment With Natalizumab

Completed
  • Relapsing Multiple Sclerosis
  • natalizumab
  • Birmingham, Alabama
  • +477 more
Sep 27, 2016

Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis Trial in Japan (natalizumab)

Completed
Has Results
  • Relapsing-Remitting Multiple Sclerosis
  • Multiple Sclerosis
  • natalizumab
  • Sapporo, Hokkaido, Japan
  • +21 more
Dec 10, 2015

Natalizumab Through Further Observational Research and

Terminated
  • Crohn's Disease
  • natalizumab
  • Scottsdale, Arizona
  • +35 more
Jul 16, 2015

Multiple Sclerosis Trial in Latham (Natalizumab)

Completed
  • Multiple Sclerosis
  • Natalizumab
  • Latham, New York
    Research Site
Feb 6, 2015

Relapsing Remitting Multiple Sclerosis Trial in Muenster (Fingolimod, Natalizumab)

Unknown status
  • Relapsing Remitting Multiple Sclerosis
  • Muenster, Germany
    Universitaetsklinikum Muenster, Department of Neurology
Dec 19, 2014

Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United States (natalizumab, standard

Completed
  • Relapsing-Remitting Multiple Sclerosis
  • Secondary Progressive Multiple Sclerosis
  • natalizumab
  • standard of care
  • Phoenix, Arizona
  • +11 more
Sep 5, 2014

Relapsing-remitting Multiple Sclerosis Trial in Lugano (interferon beta-1b, Natalizumab)

Completed
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • interferon beta-1b
  • Natalizumab
  • Lugano, Ticino, Switzerland
    Neurocenter of Southern Switzerland, Ospedale Civico Lugano
Mar 13, 2014

Relapsing Remitting Multiple Sclerosis Trial in Germany, Spain, United States (natalizumab, interferon beta 1-a,

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis
  • natalizumab
  • +4 more
  • Cullman, Alabama
  • +32 more
Sep 12, 2013

Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Copenhagen (Natalizumab)

Completed
  • Primary Progressive Multiple Sclerosis
  • Secondary Progressive Multiple Sclerosis
  • Natalizumab
  • Copenhagen, Denmark
    Danish Multiple Sclerosis Center, Section 2082, Rigshospitalet
Feb 15, 2012

Multiple Sclerosis Trial in Toulouse (Natalizumab)

Completed
  • Multiple Sclerosis
  • Natalizumab
  • Toulouse, France
    service de neurologie, hôpital Purpan
Mar 29, 2011

Multiple Sclerosis, Relapsing-Remitting Trial (Natalizumab, Placebo)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Natalizumab
  • Placebo
  • (no location specified)
Jun 17, 2009

Multiple Sclerosis Trial in Cambridge (Natalizumab)

Completed
  • Multiple Sclerosis
  • Natalizumab
  • Cambridge, Massachusetts
    Performed at only C-1801, C-1802, and C-1803 sites globally. No
Jun 19, 2009

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Natalizumab, Placebo)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Natalizumab
  • Placebo
  • Birmingham, Alabama
  • +87 more
Jun 17, 2009